世界中の市場調査レポートを販売!当社に無いレポートもお探しします。

レポートナンバー 0000029655

抗ウイルス薬の世界市場レポート(2021年版):2030年までのCOVID-19による影響と成長

The Business Research Company

Antivirals Global Market Report 2021: COVID 19 Implications And Growth to 2030

発刊日 2021/06/08

言語英語

体裁PDF/175ページ

ライセンス/価格175ページ

0000029655

Single
Site
Enterprise

※ご請求は、お申込日のTTSレートで円換算し、消費税を加えた金額になります。
※本レポートは、英文です。PDF(電子媒体)での納品となります。
※受注後、レポートは最新版へ更新されますので、納品までに3〜5営業日かかります。

無料サンプル

  • サンプルはお問い合わせください。

レポート概要

本レポートは、抗ウイルス薬市場と、新型コロナウイルス感染症(Covid 19)ウイルスによる市場への影響をカバーしています。本レポートは、戦略家、マーケティング担当者、上級管理者が、新型コロナウイルス感染症(Covid 19)患者の治療に重要な役割を果たす抗ウイルス薬の需要の増加を評価するために必要な重要な情報を提供します。

抗ウイルス薬は、新型コロナウイルス感染症(Covid 19)を含むウイルス性疾患に苦しむ患者の治療に役立ちます。

調査範囲

  • 調査市場
    ➣ 薬剤クラス別
      ◇ DNAポリメラーゼ阻害薬
      ◇ 逆転写酵素阻害薬
      ◇ プロテアーゼ阻害薬
      ◇ ノイラミニダーゼ阻害薬
      ◇ その他
    ➣ 用途別
      ◇ HIV
      ◇ 肝炎
      ◇ ヘルペス
      ◇ インフルエンザ
      ◇ その他
    ➣ タイプ別
      ◇ ブランド医薬品
      ◇ ジェネリック医薬品
  • 調査企業
    ➣ AbbVie Inc.
    ➣ Bristol-Myers-Squibb
    ➣ Cipla
    ➣ F. Hoffmann-La Roche Ltd.
    ➣ Gilead Sciences Inc.
  • 調査国
    ➣ オーストラリア
    ➣ ブラジル
    ➣ 中国
    ➣ フランス
    ➣ ドイツ
    ➣ インド
    ➣ インドネシア
    ➣ 日本
    ➣ ロシア
    ➣ 韓国
    ➣ イギリス
    ➣ アメリカ
  • 調査地域
    ➣ アジア太平洋地域
    ➣ 西ヨーロッパ
    ➣ 東ヨーロッパ
    ➣ 北アメリカ
    ➣ 南アメリカ
    ➣ 中東
    ➣ アフリカ
  • 調査期間
    ➣ 5年間の実績データおよび10年間の予測
  • データ
    ➣ 市場規模と成長の関連市場に対する比率
    ➣ GDP比率
    ➣ 1人あたりの支出
  • データセグメント
    ➣ 国別・地域別の実績および予測データ
    ➣ 競合企業の市場シェア
    ➣ 市場セグメント
  • ソースおよび参照
    ➣ 本レポートのデータおよび分析は、注釈で出典を明らかにしています。

レポート詳細

目次

Table of Contents

1. Executive Summary

2. Antivirals Market Characteristics

3. Antivirals Market Trends And Strategies

4. Impact Of COVID-19 On Antivirals

5. Antivirals Market Size And Growth
5.1. Global Antivirals Historic Market, 2015-2020, $ Billion
5.1.1. Drivers Of The Market
5.1.2. Restraints On The Market
5.2. Global Antivirals Forecast Market, 2020-2025F, 2030F, $ Billion
5.2.1. Drivers Of The Market
5.2.2. Restraints On the Market

6. Antivirals Market Segmentation
6.1. Global Antivirals Market, Segmentation By Drug Class, Historic and Forecast, 2015-2020, 2020-2025F, 2030F, $ Billion
DNA Polymerase Inhibitors
Reverse Transcriptase Inhibitors
Protease Inhibitors
Neuraminidase Inhibitors
Others
6.2. Global Antivirals Market, Segmentation By Application, Historic and Forecast, 2015-2020, 2020-2025F, 2030F, $ Billion
HIV
Hepatitis
Herpes
Influenza
Others
6.3. Global Antivirals Market, Segmentation By Type, Historic and Forecast, 2015-2020, 2020-2025F, 2030F, $ Billion
Branded
Generic

7. Antivirals Market Regional And Country Analysis
7.1. Global Antivirals Market, Split By Region, Historic and Forecast, 2015-2020, 2020-2025F, 2030F, $ Billion
7.2. Global Antivirals Market, Split By Country, Historic and Forecast, 2015-2020, 2020-2025F, 2030F, $ Billion

8. Asia-Pacific Antivirals Market
8.1. Asia-Pacific Antivirals Market Overview
Region Information, Impact Of COVID-19, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
8.2. Asia-Pacific Antivirals Market, Segmentation By Drug Class, Historic and Forecast, 2015-2020, 2020-2025F, 2030F, $ Billion

9. China Antivirals Market
9.1. China Antivirals Market Overview
9.2. China Antivirals Market, Segmentation By Drug Class, Historic and Forecast, 2015-2020, 2020-2025F, 2030F,$ Billion

10. India Antivirals Market
10.1. India Antivirals Market, Segmentation By Drug Class, Historic and Forecast, 2015-2020, 2020-2025F, 2030F, $ Billion

11. Japan Antivirals Market
11.1. Japan Antivirals Market, Segmentation By Drug Class, Historic and Forecast, 2015-2020, 2020-2025F, 2030F, $ Billion

12. Australia Antivirals Market
12.1. Australia Antivirals Market, Segmentation By Drug Class, Historic and Forecast, 2015-2020, 2020-2025F, 2030F, $ Billion

13. Indonesia Antivirals Market
13.1. Indonesia Antivirals Market, Segmentation By Drug Class, Historic and Forecast, 2015-2020, 2020-2025F, 2030F, $ Billion

14. South Korea Antivirals Market
14.1. South Korea Antivirals Market, Segmentation By Drug Class, Historic and Forecast, 2015-2020, 2020-2025F, 2030F, $ Billion

15. Western Europe Antivirals Market
15.1. Western Europe Antivirals Market Overview
15.2. Western Europe Antivirals Market, Segmentation By Drug Class, Historic and Forecast, 2015-2020, 2020-2025F, 2030F, $ Billion

16. UK Antivirals Market
16.1. UK Antivirals Market, Segmentation By Drug Class, Historic and Forecast, 2015-2020, 2020-2025F, 2030F, $ Billion

17. Germany Antivirals Market
17.1. Germany Antivirals Market, Segmentation By Drug Class, Historic and Forecast, 2015-2020, 2020-2025F, 2030F, $ Billion

18. France Antivirals Market
18.3. France Antivirals Market, Segmentation By Drug Class, Historic and Forecast, 2015-2020, 2020-2025F, 2030F, $ Billion

19. Eastern Europe Antivirals Market
19.1. Eastern Europe Antivirals Market Overview
19.2. Eastern Europe Antivirals Market, Segmentation By Drug Class, Historic and Forecast, 2015-2020, 2020-2025F, 2030F, $ Billion

20. Russia Antivirals Market
20.1. Russia Antivirals Market, Segmentation By Drug Class, Historic and Forecast, 2015-2020, 2020-2025F, 2030F, $ Billion

21. North America Antivirals Market
21.1. North America Antivirals Market Overview
21.2. North America Antivirals Market, Segmentation By Drug Class, Historic and Forecast, 2015-2020, 2020-2025F, 2030F, $ Billion

22. USA Antivirals Market
22.1. USA Antivirals Market Overview
22.2. USA Antivirals Market, Segmentation By Drug Class, Historic and Forecast, 2015-2020, 2020-2025F, 2030F, $ Billion

23. South America Antivirals Market
23.1. South America Antivirals Market Overview
23.2. South America Antivirals Market, Segmentation By Drug Class, Historic and Forecast, 2015-2020, 2020-2025F, 2030F, $ Billion

24. Brazil Antivirals Market
24.1. Brazil Antivirals Market, Segmentation By Drug Class, Historic and Forecast, 2015-2020, 2020-2025F, 2030F, $ Billion

25. Middle East Antivirals Market
25.1. Middle East Antivirals Market Overview
25.2. Middle East Antivirals Market, Segmentation By Drug Class, Historic and Forecast, 2015-2020, 2020-2025F, 2030F, $ Billion

26. Africa Antivirals Market
26.1. Africa Antivirals Market Overview
26.2. Africa Antivirals Market, Segmentation By Drug Class, Historic and Forecast, 2015-2020, 2020-2025F, 2030F, $ Billion

27. Antivirals Market Competitive Landscape And Company Profiles
27.1. Antivirals Market Competitive Landscape
27.2. Antivirals Market Company Profiles
27.2.1. AbbVie Inc.
27.2.1.1. Overview
27.2.1.2. Products and Services
27.2.1.3. Strategy
27.2.1.4. Financial Performance
27.2.2. Bristol-Myers-Squibb
27.2.2.1. Overview
27.2.2.2. Products and Services
27.2.2.3. Strategy
27.2.2.4. Financial Performance
27.2.3. Cipla
27.2.3.1. Overview
27.2.3.2. Products and Services
27.2.3.3. Strategy
27.2.3.4. Financial Performance
27.2.4. F. Hoffmann-La Roche Ltd
27.2.4.1. Overview
27.2.4.2. Products and Services
27.2.4.3. Strategy
27.2.4.4. Financial Performance
27.2.5. Gilead Sciences Inc
27.2.5.1. Overview
27.2.5.2. Products and Services
27.2.5.3. Strategy
27.2.5.4. Financial Performance

28. Antivirals Pipeline Analysis

29. Key Mergers And Acquisitions In The Antivirals Market

30. Antivirals Market Future Outlook and Potential Analysis

31. Appendix
31.1. Abbreviations
31.2. Currencies
31.3. Research Inquiries
31.4. The Business Research Company
31.5. Copyright And Disclaimer

List of Tables
Table 1: Global Historic Market Growth, 2015-2020, $ Billion
Table 2: Global Forecast Market Growth, 2020-2025F, 2030F, $ Billion
Table 3: Global Antivirals Market, Segmentation By Drug Class, Historic and Forecast, 2015-2020, 2020-2025F, 2030F, $ Billion
Table 4: Global Antivirals Market, Segmentation By Application, Historic and Forecast, 2015-2020, 2020-2025F, 2030F, $ Billion
Table 5: Global Antivirals Market, Segmentation By Type, Historic and Forecast, 2015-2020, 2020-2025F, 2030F, $ Billion
Table 6: Global Antivirals Market, Split By Region, Historic and Forecast, 2015-2020, 2020-2025F, 2030F, $ Billion
Table 7: Global Antivirals Market, Split By Country, Historic and Forecast, 2015-2020, 2020-2025F, 2030F, $ Billion
Table 8: Asia-Pacific, Antivirals Market, Segmentation By Drug Class, Historic and Forecast, 2015-2020, 2020-2025F, 2030F, $ Billion
Table 9: China, Antivirals Market, Segmentation By Drug Class, Historic and Forecast, 2015-2020, 2020-2025F, 2030F, $ Billion
Table 10: India, Antivirals Market, Segmentation By Drug Class, Historic and Forecast, 2015-2020, 2020-2025F, 2030F, $ Billion
Table 11: Japan, Antivirals Market, Segmentation By Drug Class, Historic and Forecast, 2015-2020, 2020-2025F, 2030F, $ Billion
Table 12: Australia, Antivirals Market, Segmentation By Drug Class, Historic and Forecast, 2015-2020, 2020-2025F, 2030F, $ Billion
Table 13: Indonesia, Antivirals Market, Segmentation By Drug Class, Historic and Forecast, 2015-2020, 2020-2025F, 2030F, $ Billion
Table 14: South Korea, Antivirals Market, Segmentation By Drug Class, Historic and Forecast, 2015-2020, 2020-2025F, 2030F, $ Billion
Table 15: Western Europe, Antivirals Market, Segmentation By Drug Class, Historic and Forecast, 2015-2020, 2020-2025F, 2030F, $ Billion
Table 16: UK, Antivirals Market, Segmentation By Drug Class, Historic and Forecast, 2015-2020, 2020-2025F, 2030F, $ Billion
Table 17: Germany, Antivirals Market, Segmentation By Drug Class, Historic and Forecast, 2015-2020, 2020-2025F, 2030F, $ Billion
Table 18: France, Antivirals Market, Segmentation By Drug Class, Historic and Forecast, 2015-2020, 2020-2025F, 2030F, $ Billion
Table 19: Eastern Europe, Antivirals Market, Segmentation By Drug Class, Historic and Forecast, 2015-2020, 2020-2025F, 2030F, $ Billion
Table 20: Russia, Antivirals Market, Segmentation By Drug Class, Historic and Forecast, 2015-2020, 2020-2025F, 2030F, $ Billion
Table 21: North America, Antivirals Market, Segmentation By Drug Class, Historic and Forecast, 2015-2020, 2020-2025F, 2030F, $ Billion
Table 22: USA, Antivirals Market, Segmentation By Drug Class, Historic and Forecast, 2015-2020, 2020-2025F, 2030F, $ Billion
Table 23: South America, Antivirals Market, Segmentation By Drug Class, Historic and Forecast, 2015-2020, 2020-2025F, 2030F, $ Billion
Table 24: Brazil, Antivirals Market, Segmentation By Drug Class, Historic and Forecast, 2015-2020, 2020-2025F, 2030F, $ Billion
Table 25: Middle East, Antivirals Market, Segmentation By Drug Class, Historic and Forecast, 2015-2020, 2020-2025F, 2030F, $ Billion
Table 26: Africa, Antivirals Market, Segmentation By Drug Class, Historic and Forecast, 2015-2020, 2020-2025F, 2030F, $ Billion
Table 27: AbbVie Inc. Financial Performance
Table 28: Bristol-Myers-Squibb Financial Performance
Table 29: Cipla Financial Performance
Table 30: F. Hoffmann-La Roche Ltd Financial Performance
Table 31: Gilead Sciences Inc Financial Performance

List of Figures
Figure 1: Global Historic Market Growth, 2015-2020, $ Billion
Figure 2: Global Forecast Market Growth, 2020-2025F, 2030F, $ Billion
Figure 3: Global Antivirals Market, Segmentation By Drug Class, Historic and Forecast, 2015-2020, 2020-2025F, 2030F, $ Billion
Figure 4: Global Antivirals Market, Segmentation By Application, Historic and Forecast, 2015-2020, 2020-2025F, 2030F, $ Billion
Figure 5: Global Antivirals Market, Segmentation By Type, Historic and Forecast, 2015-2020, 2020-2025F, 2030F, $ Billion
Figure 6: Global Antivirals Market, Split By Region, Historic and Forecast, 2015-2020, 2020-2025F, 2030F, $ Billion
Figure 7: Global Antivirals Market, Split By Country, Historic and Forecast, 2015-2020, 2020-2025F, 2030F, $ Billion
Figure 8: Asia-Pacific, Antivirals Market, Segmentation By Drug Class, Historic and Forecast, 2015-2020, 2020-2025F, 2030F, $ Billion
Figure 9: China, Antivirals Market, Segmentation By Drug Class, Historic and Forecast, 2015-2020, 2020-2025F, 2030F, $ Billion
Figure 10: India, Antivirals Market, Segmentation By Drug Class, Historic and Forecast, 2015-2020, 2020-2025F, 2030F, $ Billion
Figure 11: Japan, Antivirals Market, Segmentation By Drug Class, Historic and Forecast, 2015-2020, 2020-2025F, 2030F, $ Billion
Figure 12: Australia, Antivirals Market, Segmentation By Drug Class, Historic and Forecast, 2015-2020, 2020-2025F, 2030F, $ Billion
Figure 13: Indonesia, Antivirals Market, Segmentation By Drug Class, Historic and Forecast, 2015-2020, 2020-2025F, 2030F, $ Billion
Figure 14: South Korea, Antivirals Market, Segmentation By Drug Class, Historic and Forecast, 2015-2020, 2020-2025F, 2030F, $ Billion
Figure 15: Western Europe, Antivirals Market, Segmentation By Drug Class, Historic and Forecast, 2015-2020, 2020-2025F, 2030F, $ Billion
Figure 16: UK, Antivirals Market, Segmentation By Drug Class, Historic and Forecast, 2015-2020, 2020-2025F, 2030F, $ Billion
Figure 17: Germany, Antivirals Market, Segmentation By Drug Class, Historic and Forecast, 2015-2020, 2020-2025F, 2030F, $ Billion
Figure 18: France, Antivirals Market, Segmentation By Drug Class, Historic and Forecast, 2015-2020, 2020-2025F, 2030F, $ Billion
Figure 19: Eastern Europe, Antivirals Market, Segmentation By Drug Class, Historic and Forecast, 2015-2020, 2020-2025F, 2030F, $ Billion
Figure 20: Russia, Antivirals Market, Segmentation By Drug Class, Historic and Forecast, 2015-2020, 2020-2025F, 2030F, $ Billion
Figure 21: North America, Antivirals Market, Segmentation By Drug Class, Historic and Forecast, 2015-2020, 2020-2025F, 2030F, $ Billion
Figure 22: USA, Antivirals Market, Segmentation By Drug Class, Historic and Forecast, 2015-2020, 2020-2025F, 2030F, $ Billion
Figure 23: South America, Antivirals Market, Segmentation By Drug Class, Historic and Forecast, 2015-2020, 2020-2025F, 2030F, $ Billion
Figure 24: Brazil, Antivirals Market, Segmentation By Drug Class, Historic and Forecast, 2015-2020, 2020-2025F, 2030F, $ Billion
Figure 25: Middle East, Antivirals Market, Segmentation By Drug Class, Historic and Forecast, 2015-2020, 2020-2025F, 2030F, $ Billion
Figure 26: Africa, Antivirals Market, Segmentation By Drug Class, Historic and Forecast, 2015-2020, 2020-2025F, 2030F, $ Billion
Figure 27: AbbVie Inc. Financial Performance
Figure 28: Bristol-Myers-Squibb Financial Performance
Figure 29: Cipla Financial Performance
Figure 30: F. Hoffmann-La Roche Ltd Financial Performance
Figure 31: Gilead Sciences Inc Financial Performance

この商品のレポートナンバー

0000029655

TOP